Image de couverture de livre

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Amnon Sonnenberg, Anna M. Buchner, Ruth Kohen
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
par: Jannis Kountouras, et autres
Publié: (2025)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease
par: Javier Chahuán, et autres
Publié: (2026)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease
par: Jiahao Liu, et autres
Publié: (2026)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease. Authors' Reply
par: Stefano Siboni, et autres
Publié: (2026)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
par: Colin W. Howden, et autres
Publié: (2024)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
par: Walter W. Chan, et autres
Publié: (2026)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
par: Alexandra Hickey, et autres
Publié: (2025)

Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease
par: Erik Lundqvist, et autres
Publié: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
par: Monica E. W. Derks, et autres
Publié: (2025)

Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer?
par: Andrea Cassinotti, et autres
Publié: (2025)

Review Article: Individualised Management of Reflux‐Like Symptoms—Strategies Beyond Acid Suppression
par: Peter J. Kahrilas, et autres
Publié: (2025)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
par: José Luis Rueda García, et autres
Publié: (2026)

Letter: Gas‐Sensing Capsules Advance Colonic Physiology Research Toward Clinical Translation
par: Anastasios Koulaouzidis, et autres
Publié: (2025)

Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK City
par: R. Parker, et autres
Publié: (2025)

Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies
par: Sarah Manning, et autres
Publié: (2025)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease
par: Jiacheng Li
Publié: (2026)

Research Communication: Risk of Tuberculosis With Advanced Therapies in 20,705 Patients With Inflammatory Bowel Diseases in Low Incidence Regions—A U.S. Claims‐Based Study
par: Dhruv Ahuja, et autres
Publié: (2025)

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
par: Elsa L. S. A. van Liere, et autres
Publié: (2024)

The Prevalence and Risk Factors for at‐Risk MASH and Advanced Liver Fibrosis in People With Metabolic Risk Factors in Primary Care
par: Leon A. Adams, et autres
Publié: (2026)

Research Communication: Sexual Dysfunction is a Common Early Challenge in Newly Diagnosed Inflammatory Bowel Disease
par: Mohamed Attauabi, et autres
Publié: (2025)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply
par: José Luis Rueda García, et autres
Publié: (2026)

Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
par: Vlasios Gourgiotis, et autres
Publié: (2025)

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome
par: Andrea Shin, et autres
Publié: (2025)

Research Communication: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
par: Lauren Holtslander, et autres
Publié: (2025)

Editorial: Time to Genotype—Genetic Risk and Prognosis in Steatotic Liver Disease
par: Rosellina M. Mancina, et autres
Publié: (2025)

Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
par: Rahul S. Dalal, et autres
Publié: (2025)

Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial
par: Louise F. Risnes, et autres
Publié: (2025)

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Antoine Meyer, et autres
Publié: (2025)

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non‐Cirrhotic Patients
par: Ming Liu, et autres
Publié: (2025)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
par: Alyssa M. Parian, et autres
Publié: (2025)

Research Communication: Optimising Use of Stool Gluten Immunogenic Peptide Tests for Monitoring Adherence to Gluten‐Free Diet in Patients With Coeliac Disease
par: Juan P. Stefanolo, et autres
Publié: (2025)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Zhidong Zhou, et autres
Publié: (2025)

Global Burden of Gallbladder Cancer Attributable to Modifiable Risk Factors
par: Daniele Piovani, et autres
Publié: (2025)

Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease
par: Wah Loong Chan, et autres
Publié: (2024)

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
par: Michelle Spaan, et autres
Publié: (2025)

Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease—Authors' Reply
par: Jessica D. Lee, et autres
Publié: (2025)

Coronary Artery Disease and Major Adverse Cardiovascular Events in People With Hepatic Steatosis at Low Atherosclerotic Cardiovascular Disease Risk
par: Julia Karady, et autres
Publié: (2024)

Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD , MetALD and ALD
par: Nobuharu Tamaki, et autres
Publié: (2025)

Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases
par: Dhruv Ahuja, et autres
Publié: (2025)

Letter: The Hidden Truth of IBD Risk—From Antibiotics to Environmental Factors
par: Xueneng Yang, et autres
Publié: (2025)